Sign In
Get Clay Free →

Suggestions

    Adith Venkiteshwaran

    Commercializing medicines for rare diseases - Gene Therapy - Neurogenetic & Rare Muscle Diseases

    Adith Venkiteshwaran is a passionate professional focused on diagnosing, curing, and preventing diseases to improve human health.

    He has a strong background in biologics development, with notable experience in spearheading CMC development of a key diabetes asset at Eli Lilly.

    Adith has a Master of Business Administration from Harvard Business School, a Doctor of Philosophy in Biological Engineering from Rensselaer Polytechnic Institute, and a Bachelor of Science in Chemical Engineering from the University of Mumbai.

    He has held positions at reputable organizations such as Sanofi Genzyme, Decibel Therapeutics, Eli Lilly, and Genentech, showcasing his expertise in rare diseases, biologics R&D, business development, and commercialization.

    Adith is driven by innovation, simplicity, and impact, focusing on early diagnosis, behavior change, and patient-therapeutic fit in the healthcare industry.

    His dedication to advancing medical solutions and guiding teams reflects his role as a conductor orchestrating success in the complex field of drug development.

    Adith Venkiteshwaran
    Add to my network

    Location

    Cambridge, Massachusetts